Go Pro

ASP Isotopes (ASPI) 10K Form and Latest SEC Filings 2026

ASP Isotopes logo
$3.18 -0.06 (-1.70%)
As of 09:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest ASP Isotopes SEC Filings & Recent Activity

ASP Isotopes (NASDAQ:ASPI) has submitted 307+ documents to the U.S. Securities and Exchange Commission (SEC) since 2022. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in ASP Isotopes's financial statements. The most recent filing was a Form 4 submitted on September 10, 2026.

Form 4
ASP Isotopes Inc. Reports Ownership Change on Sep. 10, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
ASP Isotopes Files Current Report on Sep. 8, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
ASP Isotopes Files Quarterly Report on Aug. 14, 2026

The 10-Q contains ASP Isotopes's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

ASP Isotopes SEC Filing History

Browse ASP Isotopes' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
09/10/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2026 5:30 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
09/09/2026 5:33 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
09/08/2026 8:20 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2026 8:30 PM
ASP Isotopes (1921865) Issuer
Mann Paul Elliot (1744816) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2026 8:32 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2026 8:33 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2026 8:30 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2026 8:30 PM
ASP Isotopes (1921865) Subject
Mann Paul Elliot (1744816) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2026 11:44 AM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2026 7:22 PM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/20/2026 4:17 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2026 7:10 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/20/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2026 4:14 PM
ASP Isotopes (1921865) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2026 7:12 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2026 7:15 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/05/2026 4:07 PM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/05/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2026 4:25 PM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
08/04/2026 7:06 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2026 7:10 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2026 7:35 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
07/22/2026 5:01 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
07/21/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form D
Notice of Exempt Offering of Securities 
07/17/2026 7:20 AM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
07/16/2026 4:00 PM
ASP Isotopes (1921865) Filer
Form S-3ASR
07/16/2026 3:15 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2026 8:58 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2026 8:45 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Kiessling Heather (2026548) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Gorley Michael (2012446) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Wider Todd (1642715) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2026 8:56 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 8:45 PM
ASP Isotopes (1921865) Subject
Gorley Michael (2012446) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:04 PM
ASP Isotopes (1921865) Subject
Wider Todd (1642715) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2026 4:24 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2026 4:25 PM
ASP Isotopes (1921865) Filed by
ENDRA Life Sciences Inc. (1681682) Subject
Form 425
06/25/2026 9:15 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The dollar reset no one told you about (Ad)

Porter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-year history, back in 1974 with a secret Saudi deal that reshaped an entire generation's wealth. Today, a landmark treaty called Pax Silica - signed by 13 nations in December 2025 and barely covered in the press - is at the center of what Fortune calls 'the biggest change to the world's relationship with the dollar' in a generation. The stocks to buy, the assets to avoid, and the moves to consider are outlined in Stansberry's new briefing.tc pixel

Read the full briefing and see how to position yourself now
06/23/2026 7:00 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2026 8:48 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Kiessling Heather (2026548) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 8:45 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 8:45 PM
ASP Isotopes (1921865) Issuer
Mann Paul Elliot (1744816) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 8:45 PM
ASP Isotopes (1921865) Subject
Mann Paul Elliot (1744816) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/26/2026 7:01 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form NT 10-Q
05/11/2026 6:34 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 6:32 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 8:53 PM
ASP Isotopes (1921865) Subject
Moore Duncan (1888265) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2026 8:54 PM
ASP Isotopes (1921865) Issuer
Moore Duncan (1888265) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2026 8:54 PM
ASP Isotopes (1921865) Issuer
Kiessling Heather (2026548) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2026 8:55 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2026 4:43 PM
ASP Isotopes (1921865) Subject
Kiessling Heather (2026548) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/13/2026 8:56 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/13/2026 8:57 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2026 7:05 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2026 3:15 PM
ASP Isotopes (1921865) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/10/2026 8:03 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form NT 10-K
03/24/2026 4:15 PM
ASP Isotopes (1921865) Filer
Form 8-K/A
03/24/2026 8:39 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2026 8:15 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2026 7:22 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2026 8:45 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 8:30 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2026 7:30 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2026 6:49 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2026 8:45 PM
ASP Isotopes (1921865) Subject
Mann Paul Elliot (1744816) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 8:50 PM
ASP Isotopes (1921865) Issuer
Mann Paul Elliot (1744816) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 7:15 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2026 8:25 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2026 7:00 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2026 3:16 PM
ASP Isotopes (1921865) Subject
BNP Paribas Asset Management UK Ltd (1389277) Filed by
Form SCHEDULE 13G/A
01/29/2026 6:30 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 3:03 PM
ASP Isotopes (1921865) Subject
Encompass Capital Advisors LLC (1541901) Filed by
Form SCHEDULE 13G
01/12/2026 4:00 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2026 8:28 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2025 8:30 PM
ASP Isotopes (1921865) Issuer
Kiessling Heather (2026548) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 7:57 PM
ASP Isotopes (1921865) Issuer
Gorley Michael (2012446) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 8:01 PM
ASP Isotopes (1921865) Issuer
Hunter Ralph L. JR (2088585) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 8:02 PM
ASP Isotopes (1921865) Issuer
Ryan Robert John Andrew (2011790) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 8:03 PM
ASP Isotopes (1921865) Issuer
Wider Todd (1642715) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2025 6:06 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2025 5:29 PM
ASP Isotopes (1921865) Subject
Kiessling Heather (2026548) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The trade I’ve been waiting for since 2011 (Ad)

Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this supercycle - and says that may be conservative. Billionaire Pierre Lassonde has argued for $19,000. Former CIA advisor Jim Rickards targets $27,000 based on a federal revaluation of the gold supply. But the bigger opportunity may not be gold itself. A 'backdoor' gold-linked asset has historically multiplied gold's move by 10x or more - returning 846%, 1,668%, 1,847%, and 1,915% in the last supercycle.tc pixel

Watch the free video briefing and learn the No. 1 trade to leverage rising gold
12/18/2025 6:34 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2025 8:30 AM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 8:05 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 8:00 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2025 4:00 PM
ASP Isotopes (1921865) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2025 8:42 PM
ASP Isotopes (1921865) Issuer
Mann Paul Elliot (1744816) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 8:46 PM
Ainscow Robert (1951275) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 8:48 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 3
Initial statement of beneficial ownership of securities  
11/28/2025 8:49 PM
Ainscow Donald George (2079961) Reporting
ASP Isotopes (1921865) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

ASP Isotopes SEC Filings - Frequently Asked Questions

ASP Isotopes (ASPI) has submitted 307+ filings to the SEC since 2022. You can browse the complete history or filter by form type using the tools above.

ASP Isotopes's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on ASP Isotopes's financial statements page.

The most recent filing was a Form 4 submitted on September 10, 2026. This was an insider ownership change filed by 4 - ASP Isotopes Inc. (0001921865) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:ASPI are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 9/10/2026. New filings are added as they're published.
From Our Partners